Insights on the Current and Future Trends of the E-cigarette Supply Chain

Aug.21.2023
Insights on the Current and Future Trends of the E-cigarette Supply Chain
2FIRSTS Releases E-Cigarette Supply Chain Survey Report on Industry Trends and Performance in First Half of 2023.

As the e-cigarette industry continues to flourish, both the industry itself and the public have gained a deeper understanding of the e-cigarette supply chain. In order to gain a comprehensive understanding of the various aspects of the e-cigarette supply chain and investigate its current state, 2FIRSTS released a survey on the e-cigarette supply chain for the first half of 2023 on July 10th.


The investigation covered the current state and future prospects of supply chain companies in the e-cigarette industry. A total of 45 valid questionnaires were received, providing valuable information for the e-cigarette supply chain. Through the analysis of these data, a series of results reflecting the current industry status and future trends were obtained, which have been compiled into a report for this survey.


Outstanding performance in the first half of the year.


According to the data, more than 60% of companies achieved growth in the first half of 2023, with 11.9% even exceeding expectations. On the other hand, 19.0% of companies experienced a decline in performance as expected, while 16.7% saw a performance decline that surpassed expectations.


Optimistic Outlook for the Future of the Middle Eastern Market


In terms of market outlook for the second half of 2023, the Middle East market has received the highest rating with an average score of 4.05. Following closely behind are the Southeast Asia, Continental Europe, UK, and US markets, with scores of 3.61, 3.58, 3.41, and 3.05 respectively. However, supply chain companies have expressed a pessimistic outlook for the Russian market, giving it a meager score of 2.72.


The global atomization market is expected to continue to grow.


More than 80% of e-cigarette supply chain companies believe that the global vaporization market will continue to grow in the second half of the year. Among them, 17.8% of companies predict high growth in the market, while less than 20% of companies believe that the market will either maintain low growth or not grow at all.


The policy represents the instability of the e-cigarette market.


According to a survey, 40% of e-cigarette supply chain companies believe that the policies implemented by various countries have had a negative impact on their performance expectations. On the other hand, 33.3% of companies believe that these policies have not had a significant impact, while 26.7% believe that they have had a positive impact.


Innovative disposable e-cigarettes have become the center of attention.


In terms of product categories, disposable e-cigarettes and innovative disposable e-cigarettes have become the focus of attention for supply chain companies in the second half of 2023. However, depending on the region, the American and British markets show higher interest in innovative disposable e-cigarettes compared to disposable e-cigarettes. In the European continental market, the level of interest in various categories of e-cigarettes is similar, while the Southeast Asian, Middle Eastern, and Russian markets primarily focus on disposable e-cigarettes.


The above is a section of the survey conducted by 2FIRSTS on the e-cigarette supply chain. If you would like to obtain the complete version of the survey report and gain a detailed understanding of the current status and future trends of the e-cigarette supply chain, please click on the link below to access the full report.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech launched IKE 2.0 on September 28, initially targeting nicotine products with a platform that combines user identity verification, product authentication, configurable policy controls and data analytics. Products can be authenticated through direct device integration or NFC smart tags. IKE Tech was formed with participation from Ispire's Aspire North America, Berify and Chemular, with Ispire currently holding a 40% interest. Its age-verification component PMTA was accepted by the FDA in 2025 and remains under review. The company did not disclose customer names, commercial deployment volumes, pricing or revenue tied to IKE 2.0.
News
Sep.29 by 2Firsts Perspectives
Special Report | How Capital Is Reassessing the Global Tobacco and Modern Nicotine Industry: Lessons from a New York Forum
Special Report | How Capital Is Reassessing the Global Tobacco and Modern Nicotine Industry: Lessons from a New York Forum
Capital is reassessing the global tobacco and modern nicotine industry as heated tobacco, vaping and nicotine pouches reshape demand, profitability and regulation. At the 2026 New Approaches Summit in New York, investors and analysts examined whether smoke-free growth can sustain earnings, how regulation shapes startup value, and whether shareholder engagement can be more effective than divestment. The debate points to a broader shift: tobacco transition is increasingly becoming a capital-allocation, governance and valuation question.
Capital Markets
Oct.05
Texas Extends Tobacco Tax Interpretation to a 6-Methylnicotine Product, Citing VELO Ruling
Texas Extends Tobacco Tax Interpretation to a 6-Methylnicotine Product, Citing VELO Ruling
The Texas Comptroller of Public Accounts ruled in September 2026 that a combustible product made with non-tobacco plant material and 6-methylnicotine (6-MN), a synthetic nicotine analog, qualifies as a taxable tobacco product. The applicant said the product contained neither tobacco leaf nor measurable conventional nicotine. The determination applies reasoning from a May Texas Supreme Court decision involving VELO nicotine pouches, finding that the plant material and 6-MN together perform the functions of tobacco in a conventional smoking product. The ruling carries applicable tax, licensing and reporting obligations but is limited to the facts submitted by the taxpayer. It does not establish a blanket tax classification for all 6-MN products or extend the same conclusion to e-cigarettes.
Regulations
Nov.06
Special Report | From Oversupply to Supply Gaps: Global Tobacco Leaf Markets Diverge Ahead of 2027
Special Report | From Oversupply to Supply Gaps: Global Tobacco Leaf Markets Diverge Ahead of 2027
Global tobacco leaf markets diverged sharply in 2026, with India cutting authorised FCV production amid oversupply while Malawi faced a supply shortfall. U.S. demand improved in some leaf categories, but growers in Brazil, Colombia, Tanzania and Zimbabwe faced pressure from prices, buyer access, costs and weather. With nicotine consumption patterns also shifting, 2027 will test whether supply, demand and grower profitability can move back toward balance.
Oct.26
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
Less than a week after JUUL2 received U.S. FDA marketing authorization on August 28, 2026, JUUL Labs was sued for patent infringement in federal court in Delaware. AJ Marketing LLC filed the complaint on September 3, alleging that both JUUL 1 and JUUL2 infringe U.S. Patent No. 8,851,068 B2. The patent covers aspects of programmable electronic vaporization devices, including controls over dose delivery, usage frequency and operating parameters. The plaintiff is seeking reasonable royalties and ongoing royalties tied to the remaining life of the patent. JUUL has not yet publicly responded to the case.
Sep.10
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23